Cargando…
Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder
Gabapentin binds to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels and is used for a wide variety of on- and off-label indications. Gabapentin is dosed at total daily doses ranging from 300 to 3600 mg/d, which is generally divided into 3 doses. Although gabapentin is general...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338001/ https://www.ncbi.nlm.nih.gov/pubmed/32685337 http://dx.doi.org/10.9740/mhc.2020.07.250 |
_version_ | 1783554590704140288 |
---|---|
author | Finegan, Amber Mabrouk, Usama Nelson, Leigh Anne |
author_facet | Finegan, Amber Mabrouk, Usama Nelson, Leigh Anne |
author_sort | Finegan, Amber |
collection | PubMed |
description | Gabapentin binds to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels and is used for a wide variety of on- and off-label indications. Gabapentin is dosed at total daily doses ranging from 300 to 3600 mg/d, which is generally divided into 3 doses. Although gabapentin is generally well tolerated, 1 potential reported adverse effect is peripheral edema. However, due to the extensive number of etiologies of peripheral edema, medication causes may be overlooked on an inpatient psychiatric unit. This is a case of delayed identification of a probable adverse drug reaction to gabapentin (Naranjo score of 5) consisting of painful, 4+ pitting bilateral edema and a clear dose relationship in a patient with pervasive developmental disorder and schizoaffective disorder. |
format | Online Article Text |
id | pubmed-7338001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | College of Psychiatric & Neurologic Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-73380012020-07-16 Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder Finegan, Amber Mabrouk, Usama Nelson, Leigh Anne Ment Health Clin Case Reports Gabapentin binds to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels and is used for a wide variety of on- and off-label indications. Gabapentin is dosed at total daily doses ranging from 300 to 3600 mg/d, which is generally divided into 3 doses. Although gabapentin is generally well tolerated, 1 potential reported adverse effect is peripheral edema. However, due to the extensive number of etiologies of peripheral edema, medication causes may be overlooked on an inpatient psychiatric unit. This is a case of delayed identification of a probable adverse drug reaction to gabapentin (Naranjo score of 5) consisting of painful, 4+ pitting bilateral edema and a clear dose relationship in a patient with pervasive developmental disorder and schizoaffective disorder. College of Psychiatric & Neurologic Pharmacists 2020-07-02 /pmc/articles/PMC7338001/ /pubmed/32685337 http://dx.doi.org/10.9740/mhc.2020.07.250 Text en © 2020 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Finegan, Amber Mabrouk, Usama Nelson, Leigh Anne Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title | Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title_full | Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title_fullStr | Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title_full_unstemmed | Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title_short | Gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
title_sort | gabapentin-induced bilateral lower extremity edema in a patient with pervasive developmental disorder and schizoaffective disorder |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338001/ https://www.ncbi.nlm.nih.gov/pubmed/32685337 http://dx.doi.org/10.9740/mhc.2020.07.250 |
work_keys_str_mv | AT fineganamber gabapentininducedbilaterallowerextremityedemainapatientwithpervasivedevelopmentaldisorderandschizoaffectivedisorder AT mabroukusama gabapentininducedbilaterallowerextremityedemainapatientwithpervasivedevelopmentaldisorderandschizoaffectivedisorder AT nelsonleighanne gabapentininducedbilaterallowerextremityedemainapatientwithpervasivedevelopmentaldisorderandschizoaffectivedisorder |